Results 91 to 100 of about 1,048 (118)

Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer. [PDF]

J Control Release
Little TS, Wang Y, Chaudhari AP, Budayr OM, Tetterton-Kellner JG, Bastian AG, Brown AD, Jasiewicz NE, McCue AC, Earp HS, Miller BC, Nguyen J.   +11 more
europepmc   +1 more source

Paratope mapping of tilvestamab, an anti-AXL function-blocking antibody, using high-throughput bacterial expression of secreted scFv-osmY fusion proteins. [PDF]

Biosci Rep
Christakou E, Kursula P, Micklem D.
europepmc   +1 more source

3D bioprinted composite scaffold incorporating microfluidics-derived chondrocyte microspheroids promotes auricular cartilage regeneration. [PDF]

Mater Today Bio
Chen X, Hu H, Yang J, Wang Y, Yue W, Xing P, Zhang Y, Chen J, Xu T, Li Y.   +9 more
europepmc   +1 more source

Development of anti-dengue virus D8 neutralizing monoclonal antibody production in <i>Nicotiana benthamiana</i>. [PDF]

Biotechnol Rep (Amst)
Niyompun G, Rattanapisit K, Jaratsittisin J, Suwanchaikasem P, Sootichote R, Sittikul P, Pitaksajjakul P, Ramasoota P, Phoolcharoen W.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

How to estimate expected credit losses – ECL – for provisioning under IFRS 9

The Journal of Risk Finance, 2021
PurposeThis paper provides an objective approach based on available market information capable of reducing subjectivity, inherently present in the process of expected loss provisioning under the IFRS 9.Design/methodology/approachThis paper develops the two-step methodology.
openaire   +1 more source

Accounting Treatment of Credit Loss Allowances Amid COVID-19: Current Expected Credit Loss (CECL) Versus IFRS 9 Expected Credit Loss (ECL)

SSRN Electronic Journal, 2020
Shortly before the COVID-19 crisis emerged worldwide accounting standard boards reformed the accounting requirements for the modeling and the accounting of credit loss allowances. The Financial Standards Board (FASB) issues new requirements effective 2020 and the International Accounting Standards Board (IASB) IFRS 9 becoming effective 2018. The crisis
openaire   +1 more source

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

Ca-A Cancer Journal for Clinicians, 2021
Amila K Nanayakkara, Vance G Fowler, Kevin Outterson   +2 more
exaly  

Implementing Expected Credit Loss ECL) in the Iranian Banking Industry

2022
openaire   +1 more source

A Propsed Framework to Audit of Expected credit loss "ECL" Estimate Uncertainty

مجلة الدراسات والبحوث التجارية, 2020
openaire   +1 more source

Oxygen Loss in Layered Oxide Cathodes for Li-Ion Batteries: Mechanisms, Effects, and Mitigation

Chemical Reviews, 2022
Hanlei Zhang, Hao Liu, Louis F J Piper
exaly